Coya Therapeutics, Inc.
COYA
$6.08
-$0.02-0.33%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/1/2025
-
GuruFocus
4/1/2025
-
Business Wire
3/31/2025
-
MarketBeat
3/28/2025
-
MarketBeat
3/28/2025
-
MarketBeat
3/27/2025
-
Zacks Investment Research
3/27/2025
-
Zacks Investment Research
3/27/2025
-
Zacks Investment Research
3/26/2025
-
GuruFocus
3/26/2025
-
The Fly
3/26/2025
-
Business Wire
3/26/2025
-
Business Wire
3/21/2025
-
MarketBeat
3/21/2025
-
TipRanks Financial Blog
3/19/2025
-
MarketBeat
3/19/2025
-
MarketBeat
3/19/2025
-
SeekingAlpha.com: All News
3/18/2025
-
Ticker Report
3/18/2025
-
GuruFocus
3/18/2025
-
GuruFocus
3/18/2025
-
Business Wire
3/10/2025
-
MarketBeat
3/4/2025
-
MarketBeat
2/25/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 18, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
800 587 8170
Address
5850 San Felipe Street
Houston, TX 77057
Houston, TX 77057
Country
Year Founded
Business Description
Sector
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). Its product...
more
